CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.

CONCLUSIONS: CD110 promotes pancreatic cancer progression and it may serve as a predictive factor for liver metastasis.
PMID: 30770989 [PubMed - as supplied by publisher]

Source: Clin Med Res - February 15, 2019 Category: Research Authors: Yan Z, Ohuchida K, Zheng B, Okumura T, Takesue S, Nakayama H, Iwamoto C, Shindo K, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M Tags: J Cancer Res Clin Oncol Source Type: research